Abstract
Botulinum neurotoxin (BoNT) inhibits the release of acetylcholine from cholinergic nerve terminals in muscles or salivary glands. With reduced activation, the muscle activity or secretion decreases. Indications for medical, non‐cosmetic use of BoNT in the orofacial area include among others oromandibular dystonia, painful masseter hypertrophy, Frey's syndrome, and severe drooling. The chapter covers anamnestic characteristics of these conditions as well as clinical, electromyographic (EMG) and laboratory findings, treatment methods with guided injections, and outcome from systematic treatment controls and follow‐up examinations.
| Original language | English |
|---|---|
| Title of host publication | Botulinum Toxin Therapy Manual for Dystonia and Spasticity |
| Editors | R Rosales, D Dressler |
| Number of pages | 17 |
| Place of Publication | Rijeka |
| Publisher | InTechOpen |
| Publication date | 2016 |
| Pages | 79-95 |
| Chapter | 7 |
| ISBN (Print) | 978-953-51-2852-6 |
| ISBN (Electronic) | 978-953-51-2851-9 |
| DOIs | |
| Publication status | Published - 2016 |